Scott Borland

Scott Borland has extensive work experience in the pharmaceutical and biotech industry. Scott currently serves as the Global Program Team Leader for the Ophthalmology Franchise at Annexon Biosciences. Prior to this, they held the position of CEO and President/Program Team Leader at Xoc Pharmaceuticals for nearly nine years. Before joining Xoc Pharmaceuticals, they served as the Senior Vice President and Neurology Franchise Program Leader at MAP Pharmaceuticals, which was later acquired by Allergan. Scott also held the role of Vice President of Engineering at Capnia, Inc. and Senior Director of Engineering and Operations at Aerogen. Overall, Scott Borland has a diverse range of leadership roles in various companies within the pharmaceutical and biotech industry.

Scott Borland completed their Bachelor's of Science degree in Materials Science and Engineering from the University of Arizona between the years 1988 and 1992. Following this, they pursued a Master's of Science degree in Chemical Engineering from the Massachusetts Institute of Technology, which they completed between 1992 and 1995.